Literature DB >> 15845768

Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity.

Nikhil K Basu1, Martina Kovarova, Amanda Garza, Shigeki Kubota, Tapas Saha, Partha S Mitra, Rajat Banerjee, Juan Rivera, Ida S Owens.   

Abstract

UDP-glucuronosyltransferase (UGT) isozymes catalyze detoxification of numerous chemical toxins present in our daily diet and environment by conjugation to glucuronic acid. The special properties and enzymatic mechanism(s) that enable endoplasmic reticulum-bound UGT isozymes to convert innumerable structurally diverse lipophiles to excretable glucuronides are unknown. Inhibition of cellular UGT1A7 and UGT1A10 activities and of [33P]orthophosphate incorporation into immunoprecipitable proteins after exposure to curcumin or calphostin-C indicated that the isozymes are phosphorylated. Furthermore, inhibition of UGT phosphorylation and activity by treatment with PKCepsilon-specific inhibitor peptide supported PKC involvement. Co-immunoprecipitation, colocalization by means of immunofluorescence, and cross-linking studies of PKCepsilon and UGT1A7His revealed that the proteins reside within 11.4 angstroms of each other. Moreover, mutation of three PKC sites in each UGT isozyme demonstrated that T73A/G and T202A/G caused null activity, whereas S432G-UGT1A7 caused a major shift of its pH-8.5 optimum to 6.4 with new substrate selections, including 17beta-estradiol. S432G-UGT1A10 exhibited a minor pH shift without substrate alterations. PKCepsilon involvement was confirmed by the demonstration that PKCepsilon overexpression enhanced activity of UGT1A7 but not of its S432 mutant and the conversion of 17beta-[14C]estradiol by S432G-UGT1A7 but not by UGT1A7. Consistent with these observations, treatment of UGT1A7-transfected cells with PKCepsilon-specific inhibitor peptide or general PKC inhibitors increased 17beta-estradiol catalysis between 5- and 11-fold, with parallel decreases in phosphoserine-432. Here, we report a mechanism involving PKC-mediated phosphorylation of UGT such that phosphoserine/threonine regulates substrate specificity in response to chemical exposures, which possibly confers survival benefit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845768      PMCID: PMC1088353          DOI: 10.1073/pnas.0407872102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The specificity of glucose 6-phosphatase of intact liver microsomes.

Authors:  W J Arion; B K Wallin; P W Carlson; A J Lange
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

2.  Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase.

Authors:  G Zhu; D Wang; Y H Lin; T McMahon; E H Koo; R O Messing
Journal:  Biochem Biophys Res Commun       Date:  2001-07-27       Impact factor: 3.575

3.  Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.

Authors:  M Ciotti; N Basu; M Brangi; I S Owens
Journal:  Biochem Biophys Res Commun       Date:  1999-06-24       Impact factor: 3.575

4.  Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency.

Authors:  S M de Morais; P G Wells
Journal:  Hepatology       Date:  1989-08       Impact factor: 17.425

5.  Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity.

Authors:  Nikhil K Basu; Labanyamoy Kole; Ida S Owens
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

6.  Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake.

Authors:  Nikhil K Basu; Marco Ciotti; Myung S Hwang; Labanyamoy Kole; Partha S Mitra; Jeong W Cho; Ida S Owens
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

7.  Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.

Authors:  Nikhil K Basu; Shigeki Kubota; Meselhy R Meselhy; Marco Ciotti; Bhabadeb Chowdhury; Masao Hartori; Ida S Owens
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

8.  Human UDP-glucuronosyltransferases show atypical metabolism of mycophenolic acid and inhibition by curcumin.

Authors:  Nikhil K Basu; Labanyamoy Kole; Shigeki Kubota; Ida S Owens
Journal:  Drug Metab Dispos       Date:  2004-07       Impact factor: 3.922

9.  Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.

Authors:  David M Tillman; Kamel Izeradjene; Kinga Szekely Szucs; Leslie Douglas; Janet A Houghton
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells.

Authors:  J K Ritter; J M Crawford; I S Owens
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

View more
  17 in total

1.  Two Medicago truncatula half-ABC transporters are essential for arbuscule development in arbuscular mycorrhizal symbiosis.

Authors:  Quan Zhang; Laura A Blaylock; Maria J Harrison
Journal:  Plant Cell       Date:  2010-05-07       Impact factor: 11.277

2.  Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers.

Authors:  Laurie P Volak; Michael J Hanley; Gina Masse; Suwagmani Hazarika; Jerold S Harmatz; Vladimir Badmaev; Muhammed Majeed; David J Greenblatt; Michael H Court
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity.

Authors:  Sunit K Chakraborty; Nikhil K Basu; Sirsendu Jana; Mousumi Basu; Amit Raychoudhuri; Ida S Owens
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 4.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

5.  Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS/MS method determines its turnover number and correlates with its glucuronidation activities.

Authors:  Beibei Xu; Song Gao; Baojian Wu; Taijun Yin; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2013-08-29       Impact factor: 3.935

6.  Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Authors:  Stacie M Bratton; Carrie M Mosher; Farid Khallouki; Moshe Finel; Michael H Court; Jeffery H Moran; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

Review 7.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

8.  Src supports UDP-glucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancer.

Authors:  Partha S Mitra; Nikhil K Basu; Ida S Owens
Journal:  Biochem Biophys Res Commun       Date:  2009-03-14       Impact factor: 3.575

9.  Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.

Authors:  Ryan W Dellinger; Angela M Gomez Garcia; Frank L Meyskens
Journal:  Drug Metab Pharmacokinet       Date:  2013-08-20       Impact factor: 3.614

10.  Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.

Authors:  Nikhil K Basu; Labanyamoy Kole; Mousumi Basu; Antony F McDonagh; Ida S Owens
Journal:  Biochem Biophys Res Commun       Date:  2007-06-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.